BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 37530079)

  • 21. Frequency of heterozygous germline pathogenic variants in genes for Fanconi anemia in patients with non-BRCA1/BRCA2 breast cancer: a meta-analysis.
    Alter BP; Best AF
    Breast Cancer Res Treat; 2020 Jul; 182(2):465-476. PubMed ID: 32488392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
    Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
    J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and Spectrum of
    Foglietta J; Ludovini V; Bianconi F; Pistola L; Reda MS; Al-Refaie A; Tofanetti FR; Mosconi A; Minenza E; Anastasi P; Molica C; Stracci F; Roila F
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A knowledge-based framework for the discovery of cancer-predisposing variants using large-scale sequencing breast cancer data.
    Melloni GEM; Mazzarella L; Bernard L; Bodini M; Russo A; Luzi L; Pelicci PG; Riva L
    Breast Cancer Res; 2017 May; 19(1):63. PubMed ID: 28569218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The detection of germline and somatic BRCA1/2 genetic variants through parallel testing of patients with high-grade serous ovarian cancer: a national retrospective audit.
    Frugtniet B; Morgan S; Murray A; Palmer-Smith S; White R; Jones R; Hanna L; Fuller C; Hudson E; Mullard A; Quinton AE
    BJOG; 2022 Feb; 129(3):433-442. PubMed ID: 34657373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline variants in hereditary breast cancer genes are associated with early age at diagnosis and family history in Guatemalan breast cancer.
    Ren M; Orozco A; Shao K; Albanez A; Ortiz J; Cao B; Wang L; Barreda L; Alvarez CS; Garland L; Wu D; Chung CC; Wang J; Frone M; Ralon S; Argueta V; Orozco R; Gharzouzi E; Dean M
    Breast Cancer Res Treat; 2021 Sep; 189(2):533-539. PubMed ID: 34196900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic acinar cell carcinoma is associated with
    Kryklyva V; Haj Mohammad N; Morsink FHM; Ligtenberg MJL; Offerhaus GJA; Nagtegaal ID; de Leng WWJ; Brosens LAA
    Cancer Biol Ther; 2019; 20(7):949-955. PubMed ID: 31002019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
    Zeng C; Guo X; Wen W; Shi J; Long J; Cai Q; Shu XO; Xiang Y; Zheng W
    Breast Cancer Res Treat; 2020 Jun; 181(2):465-473. PubMed ID: 32318955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor sequencing is useful to refine the analysis of germline variants in unexplained high-risk breast cancer families.
    Van Marcke C; Helaers R; De Leener A; Merhi A; Schoonjans CA; Ambroise J; Galant C; Delrée P; Rothé F; Bar I; Khoury E; Brouillard P; Canon JL; Vuylsteke P; Machiels JP; Berlière M; Limaye N; Vikkula M; Duhoux FP
    Breast Cancer Res; 2020 Apr; 22(1):36. PubMed ID: 32295625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apparent regional differences in the spectrum of BARD1 pathogenic variants in Spanish population and importance of copy number variants.
    Benito-Sánchez B; Barroso A; Fernández V; Mercadillo F; Núñez-Torres R; Pita G; Pombo L; Morales-Chamorro R; Cano-Cano JM; Urioste M; González-Neira A; Osorio A
    Sci Rep; 2022 May; 12(1):8547. PubMed ID: 35595798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Yield of targeted genotyping for the recurring pathogenic variants in cancer susceptibility genes in a healthy, multiethnic Israeli population.
    Bernstein-Molho R; Galmor L; Laitman Y; Segev S; Friedman E
    Cancer; 2021 Oct; 127(19):3599-3604. PubMed ID: 34157778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers.
    Milne RL; Antoniou AC
    Ann Oncol; 2011 Jan; 22 Suppl 1():i11-7. PubMed ID: 21285145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand.
    Sukpan P; Kanokwiroon K; Sriplung H; Laochareonsuk W; Choochuen P; Auseng N; Wanawanakorn K; Sangkhathat S
    Asian Pac J Cancer Prev; 2023 Feb; 24(2):525-530. PubMed ID: 36853301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma.
    Nassar AH; Abou Alaiwi S; AlDubayan SH; Moore N; Mouw KW; Kwiatkowski DJ; Choueiri TK; Curran C; Berchuck JE; Harshman LC; Nuzzo PV; Chanza NM; Van Allen E; Esplin ED; Yang S; Callis T; Garber JE; Rana HQ; Sonpavde G
    Genet Med; 2020 Apr; 22(4):709-718. PubMed ID: 31844177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hereditary variants of unknown significance in African American women with breast cancer.
    McDonald JT; Ricks-Santi LJ
    PLoS One; 2022; 17(10):e0273835. PubMed ID: 36315513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of Pathogenic Germline Variants Among Patients With Advanced Colorectal Cancer Undergoing Tumor Genomic Profiling for Precision Medicine.
    You YN; Borras E; Chang K; Price BA; Mork M; Chang GJ; Rodriguez-Bigas MA; Bednarski BK; Meric-Bernstam F; Vilar E
    Dis Colon Rectum; 2019 Apr; 62(4):429-437. PubMed ID: 30730459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Susceptibility study on the germline rare variants of bromodomain and extraterminal domain protein family-encoding genes and patients with cancer living in some regions of China].
    Huang Y; Li JH; Wang X; Zou Y; Huang WF; Liu C; Zhang H
    Zhonghua Yi Xue Za Zhi; 2022 Nov; 102(42):3374-3381. PubMed ID: 36372767
    [No Abstract]   [Full Text] [Related]  

  • 38. Clinical Impact of Next-Generation Sequencing Multi-Gene Panel Highlighting the Landscape of Germline Alterations in Ovarian Cancer Patients.
    Gurioli G; Tedaldi G; Farolfi A; Petracci E; Casanova C; Comerci G; Danesi R; Arcangeli V; Ravegnani M; Calistri D; Zampiga V; Cangini I; Fonzi E; Virga A; Tassinari D; Rosati M; Ulivi P; De Giorgi U
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.
    Saxena S; Chakraborty A; Kaushal M; Kotwal S; Bhatanager D; Mohil RS; Chintamani C; Aggarwal AK; Sharma VK; Sharma PC; Lenoir G; Goldgar DE; Szabo CI
    BMC Med Genet; 2006 Oct; 7():75. PubMed ID: 17018160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and Prognostic Role of BRCA1/2 Variants in Unselected Chinese Breast Cancer Patients.
    Zhong X; Dong Z; Dong H; Li J; Peng Z; Deng L; Zhu X; Sun Y; Lu X; Shen F; Su X; Zhang L; Gu Y; Zheng H
    PLoS One; 2016; 11(6):e0156789. PubMed ID: 27257965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.